SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is experiencing a massive sell-off following a significant earnings miss and weak forward guidance, triggering intense investor frustration and widespread calls for a management overhaul. The community is actively debating whether the stock is a deep-value turnaround play given its remaining cash position or a terminal failure as growth concerns and executive turnover dominate the conversation.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investors weigh speculation about a potential buyout against concerns over earnings performance and margin pressure. Community sentiment is deeply polarized, with many retail participants focused on the stock's high short interest and institutional ownership as catalysts for a potential squeeze, while others remain skeptical given ongoing operational challenges.

Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. The company was founded by Shari Buck, Konstantin Guericke, Nate Gross, and Jeffrey A. Tangney on April 16, 2010 and is headquartered in San Francisco, CA.

Doximity Inc - Ordinary Shares - Class A

Doximity Inc

Doximity is trending due to significant volatility following its latest earnings report, which triggered a sharp sell-off despite headline beats on both revenue and earnings. The community is sharply divided, with bulls pointing to the company's strong margins and cash-rich balance sheet as reasons to buy the dip, while bears are highlighting concerns over decelerating growth guidance and insider selling as catalysts for further downside.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing heightened scrutiny and market volatility as investors weigh disappointing earnings expectations against the company's aggressive growth in prediction markets ahead of the upcoming NFL season. While the community remains deeply divided between those betting on a generational buying opportunity and those frustrated by persistent revenue pressure, the primary conversation revolves around whether the core sportsbook business can sustain its momentum amid intense industry competition.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing significant volatility and downward pressure after missing top and bottom-line estimates for the second quarter, fueling intense debate over the brand's long-term growth trajectory. Investors are actively split, with many questioning management's strategy regarding SKU optimization and the core brand's performance, while others are eyeing the sharp decline as a potential entry point for a long-term turnaround play.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is facing intense investor scrutiny as the silence following its PDUFA date for RP1 stretches, fueling intense speculation between a potential third CRL or a complex conditional approval. Community sentiment remains deeply divided, with bulls pointing to the positive AdCom vote as proof of pending success, while skeptics emphasize the lack of communication, underlying trial design concerns, and the high probability of immediate dilution if a commercial launch proceeds.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. The firm offers various products for application security, performance and reliability, network services, Zero Trust, developer platform, media delivery, insights, domain registration, and consumer services. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is trending as investors weigh a strong earnings beat and raised guidance against a sharp pullback sparked by a major workforce restructuring. While the community is debating whether the layoffs signal necessary efficiency gains or broader AI-related demand concerns, many are actively positioning themselves to buy the dip, citing the company's critical role in the expanding 'Agentic Internet' infrastructure.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is experiencing a significant surge in momentum following strong quarterly results, with investors cheering accelerating cloud revenue and the successful integration of AI tools. The stock has become a focal point for community discussions as traders weigh whether this software rally marks a definitive end to sector-wide pessimism or serves as a tactical short-squeeze opportunity.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance is surging following a blowout earnings report that shattered analyst expectations, with revenue growth and margin expansion signaling strong commercial momentum for its flagship TIL therapy. The community is buzzing over management's upbeat commentary on the lung cancer pipeline and the resolution of the Replimmune competitive overhang, fueling widespread calls for a sustained rally as institutional re-evaluation begins.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is facing heightened community skepticism following a disappointing earnings report that missed estimates, with investors increasingly frustrated by the company's reliance on projected revenue growth rather than confirmed contract wins. While some long-term bulls remain committed to the company's defense-focused drone and autonomous vessel portfolio, many are demanding immediate execution and evidence of sales to justify the current valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Doximity Stock is Up More Than 70% in After-Hours Trading Thursday

Doximity stock is soaring after Q4 results and revised guidance. Here's what investors need to know.read more...

Doximity (DOCS) Q1 Earnings Lag Estimates

Doximity (DOCS) delivered earnings and revenue surprises of -3.33% and +3.24%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market session. The market value of their outstanding shares is at $3.8 billion. The company's, Q1 earnings came outread more...

Doximity Announces Fiscal 2027 First Quarter Financial Results

Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 first quarter ended June 30, 2026. We're proud that our clinical AI assistant, Doximity Ask, was the top-performing U.S.-based model in the NOHARM benchmark while we...

Ahead of Doximity (DOCS) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Doximity (DOCS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.

Doximity (DOCS) Laps the Stock Market: Here's Why

Doximity (DOCS) concluded the recent trading session at $20.99, signifying a +2.79% move from its prior day's close.

Doximity (DOCS) Declines More Than Market: Some Information for Investors

Doximity (DOCS) closed at $21.52 in the latest trading session, marking a -3.11% move from the prior day.

Reasons to Retain Doximity Stock in Your Portfolio for Now

DOCS is ramping up AI across physician workflows and enterprise tools, but weak pharma ads and higher AI spending may test near-term growth.

Doximity to Release Fiscal 2027 First Quarter Results on August 6, 2026

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2026 after market close on August 6, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00...

Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety

Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Doximity Ask, its HIPAA-compliant clinical AI platform, outperformed leading frontier AI models in the NOHARM (Numerous Options Harm Assessment for Risk in Medicine) benchmark, one of the...

$DOCS Q1 &#39;27 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.13 down -53.57% YoY
• Reported revenue of $156.62M up 7.34% YoY
• Doximity provides guidance for the fiscal second quarter ending September 30, 2026, with revenue between $170 million and $171 million and adjusted EBITDA between $80.5 million and $81.5 million for Doximity.

Stocktwits

 Q1 '27 Earnings Results & Recap

• Reported GAAP EPS of $0.13 down -53.57% YoY
• Reported revenue of $156.62M up 7.34% YoY
• Doximity provides guidance for the fiscal second quarter ending September 30, 2026, with revenue between $170 million and $171 million and adjusted EBITDA between $80.5 million and $81.5 million for Doximity.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Why Did DOCS Stock Plunge 35% In Pre-Market Today?

Equity

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits Polls

Traders are fiercely debating whether the massive post-earnings price surge is a genuine breakout or a violent squeeze against heavily shorted positions.

Confusion persists among investors regarding the disconnect between modest financial results and the stock's astronomical aftermarket move.

Aggressive retail participants are clashing with bearish traders, with many claiming shorts are being 'toasted' as volume spikes significantly.

Feed

News

Sentiment

Earnings

Fundamentals

Info

DOCSDoximity Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest DOCS News